InvestorsHub Logo
Followers 4
Posts 280
Boards Moderated 0
Alias Born 04/12/2012

Re: nutsyprofessor post# 1960

Tuesday, 01/07/2014 8:10:42 PM

Tuesday, January 07, 2014 8:10:42 PM

Post# of 14982
You're a smart guy but that statement is pretty ignorant-

Viagra was originally an attempt to treat hypertension- it had the inadvertent side effect of increased blood supply to the penis and they pushed forward to treat erectile dysfunction primarily.

CV value was unexpected- patent applied- what they can do it with- basically anything they want- Libigel was found safe so you don't think that, at its worst, it can be used off label for CV purposes like T is already for FSD? Even at its worst it would drive sales of libigel solely for the off label use.



How about you reply to JTFM as follows:

Hey JTFM, you're right- not only will they be treating deficient T-levels but maybe serve dual purpose with the CV benefits; Libigel is safe, what would there be to lose for the cardiac patient with their limited options of medical treatment's on the market given libigel's safety and CV benefits. Viagra not only treats ED but also hypertension- Libigel can fall in the same category. Also, I'm not an MM nor am I shorting this stock.

That would be a better reply
-RG
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ANIP News